BE812909A - Perfectionnements a l'obtention de preparations de medicaments a administration par voie orale - Google Patents

Perfectionnements a l'obtention de preparations de medicaments a administration par voie orale

Info

Publication number
BE812909A
BE812909A BE142515A BE142515A BE812909A BE 812909 A BE812909 A BE 812909A BE 142515 A BE142515 A BE 142515A BE 142515 A BE142515 A BE 142515A BE 812909 A BE812909 A BE 812909A
Authority
BE
Belgium
Prior art keywords
oral administration
medicinal preparations
obtaining medicinal
obtaining
preparations
Prior art date
Application number
BE142515A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE812909A publication Critical patent/BE812909A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE142515A 1973-03-28 1974-03-27 Perfectionnements a l'obtention de preparations de medicaments a administration par voie orale BE812909A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1492073A GB1468172A (en) 1973-03-28 1973-03-28 Oral drug preparations

Publications (1)

Publication Number Publication Date
BE812909A true BE812909A (fr) 1974-07-15

Family

ID=10049906

Family Applications (1)

Application Number Title Priority Date Filing Date
BE142515A BE812909A (fr) 1973-03-28 1974-03-27 Perfectionnements a l'obtention de preparations de medicaments a administration par voie orale

Country Status (14)

Country Link
US (1) US3917813A (nl)
JP (1) JPS5414649B2 (nl)
BE (1) BE812909A (nl)
CA (1) CA1029658A (nl)
CH (1) CH585556A5 (nl)
DE (1) DE2414868B2 (nl)
FI (1) FI58069C (nl)
FR (1) FR2223047B1 (nl)
GB (1) GB1468172A (nl)
NL (1) NL182369C (nl)
NO (1) NO142155C (nl)
SE (1) SE413578B (nl)
SU (1) SU665778A3 (nl)
ZA (1) ZA741963B (nl)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet
AR216922A1 (es) * 1976-11-11 1980-02-15 Merck Patent Gmbh Procedimiento para la fabricacion de un medio quirurgico
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
US4218433A (en) * 1977-03-03 1980-08-19 Nippon Kayaku Kabushiki Kaisha Constant-rate eluting tablet and method of producing same
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4196187A (en) * 1977-09-02 1980-04-01 Eastman Kodak Company Rumen-stable pellets
US4181709A (en) * 1977-09-02 1980-01-01 Eastman Kodak Company Rumen-stable pellets
US4181708A (en) * 1977-09-02 1980-01-01 Eastman Kodak Company Rumen-stable pellets
US4177255A (en) * 1977-09-02 1979-12-04 Eastman Kodak Company Rumen-stable pellets
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3126703A1 (de) 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
WO1984000004A1 (en) * 1982-06-14 1984-01-05 Key Pharma Sustained release aspirin
WO1984000295A1 (en) * 1982-07-09 1984-02-02 Key Pharma Sustained release quinidine dosage form
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4716041A (en) * 1984-02-10 1987-12-29 A/S Alfred Benzon Diffusion coated multiple-units dosage form
US4618487A (en) * 1984-07-06 1986-10-21 Alza Corporation Device for administering calcium ascorbate
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5149775A (en) * 1991-01-25 1992-09-22 Eastman Kodak Company Method for purifying high molecular weight vinylpyridine/styrene polymers from solution
ATE120089T1 (de) * 1991-05-20 1995-04-15 Marion Laboratories Inc Mehrschichtige zubereitung mit kontrollierter freisetzung.
US5518737A (en) * 1991-10-16 1996-05-21 Orion-Yhtyma Oy Peroral drug delivery system
ES2328191T3 (es) * 1997-03-14 2009-11-10 Toray Industries, Inc. Preparacion de derivado de la prostaglandina i de liberacion sostenida.
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
ES2531215T3 (es) * 2006-01-27 2015-03-11 Aptalis Pharmatech Inc Sistemas de administración de fármacos que comprenden un agente de bloqueo selectivo de la serotonina 5-HT3 débilmente básico y ácidos orgánicos
NZ569984A (en) * 2006-01-27 2011-06-30 Eurand Inc Drug delivery systems comprising weakly basic drugs and organic acids
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2971889A (en) * 1958-03-18 1961-02-14 Smith Kline French Lab Press coated enteric tablets and process for preparing them
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
US3584113A (en) * 1967-08-31 1971-06-08 Eisai Co Ltd Process for the production of medical preparations having sustained release of therapeutical effect
BE744162A (fr) * 1969-01-16 1970-06-15 Fuji Photo Film Co Ltd Procede d'encapsulage
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US3629392A (en) * 1969-08-15 1971-12-21 Gilbert S Banker Entrapment compositions and processes
US3608063A (en) * 1969-08-15 1971-09-21 Gilbert S Banker Molecular drug entrapment process and compositions
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen

Also Published As

Publication number Publication date
JPS5414649B2 (nl) 1979-06-08
NO142155C (no) 1980-07-09
NO741084L (no) 1974-10-01
FR2223047A1 (nl) 1974-10-25
NL182369B (nl) 1987-10-01
CH585556A5 (nl) 1977-03-15
AU6726974A (en) 1975-10-02
FR2223047B1 (nl) 1978-08-18
SU665778A3 (ru) 1979-05-30
NL182369C (nl) 1988-03-01
DE2414868B2 (de) 1980-04-30
US3917813A (en) 1975-11-04
CA1029658A (en) 1978-04-18
FI58069B (fi) 1980-08-29
SE413578B (sv) 1980-06-09
GB1468172A (en) 1977-03-23
DE2414868A1 (de) 1974-10-10
ZA741963B (en) 1975-03-26
JPS5029729A (nl) 1975-03-25
DE2414868C3 (nl) 1987-07-09
FI58069C (fi) 1980-12-10
NL7404134A (nl) 1974-10-01
NO142155B (no) 1980-03-31

Similar Documents

Publication Publication Date Title
BE812909A (fr) Perfectionnements a l'obtention de preparations de medicaments a administration par voie orale
FR2285896A1 (fr) Preparation pharmaceutique destinee a l'administration dans la cavite buccale
PH13841A (en) Pharmaceutical preparation adapted for oral administration
BE849632A (fr) Composition pharmaceutique pour l'administration orale
DK156375C (da) Praeparater til oral administration til droevtyggere med langvarig medikamentafgivelse
IL42232A0 (en) Dry medicines for oral administration
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
BE845613A (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone
PT65950B (fr) Nouveaux medicaments derives de l'indole
BE829058A (fr) Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle
BE804645A (fr) Dispositif pour l'administration de medicaments par inhalation orale
BE800695A (fr) Preparations pharmaceutiques a administrer par voie orale contenant de l'agglutinine
BE827595A (fr) Medicament a administration par voie orale produisant un effet inhibiteur de l'antiplasmine
IT8349395A0 (it) Prerarato farmaceutico a base di di gossina per ingestione orale
IT1060117B (it) 4 alchil diossi alchilen 5 benzil pirimidine, procedimento per la loro preparazione e preparati medicinali
BE872647A (fr) Composition pharmaceutique administrable par voie orale
BE810385A (fr) Compositions medicamenteuses pour l'administration par voie orale
BE811547A (fr) Medicament a base d'un derive de la 7h-benzocycloheptene-7-one
AU5512273A (en) Medicinal preparations for oral use
BE806158A (fr) Medicament a base d'ergocornine ou de 2-bromo-alpha-ergokryptine
BE801014A (fr) Medicament a base d'(hydroxy-2 indanyl-2)1 propylamine
GB1367608A (en) Oral pharmaceutical dosage form
BE823487A (fr) Medicament a base de vincamine
BE770844A (fr) Medicament a base d'un derive de diphenyl-alcane
BE880648A (fr) Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: A/S ALFRED BENZON

Effective date: 19940327